Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc. - Re: Settlement May Be Preferable to Trial / Appeal in Terms of Risk

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Back To Forum List View

Settlement May Be Preferable to Trial / Appeal in Terms of Risk

MagBeach

Dec 12, 2007 10:16AM

lake3054

Rank: Vice President [?]

Points: 6096 [?]

Votes: 76 Score: 3.0 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Settlement May Be Preferable to Trial / Appeal in Terms of Risk

in response to

Settlement May Be Preferable to Trial / Appeal in Terms of Risk

MagBeach

posted on Dec 12, 2007 10:20AM

...except I believe it was posted here awhile back that EDoT's "overturned on appeal" rate was under / around 20% (meaning 80% +/- were upheld in favor of the plaintiff? Did I rememeber that stat correctly?

Reply New Message

Back To Forum List View

Please to post a reply